182 related articles for article (PubMed ID: 32829096)
1. Screening non-MAPT genes of the Chr17q21 H1 haplotype in Parkinson's disease.
Soto-Beasley AI; Walton RL; Valentino RR; Hook PW; Labbé C; Heckman MG; Johnson PW; Goff LA; Uitti RJ; McLean PJ; Springer W; McCallion AS; Wszolek ZK; Ross OA
Parkinsonism Relat Disord; 2020 Sep; 78():138-144. PubMed ID: 32829096
[TBL] [Abstract][Full Text] [Related]
2.
Shani S; Gana-Weisz M; Bar-Shira A; Thaler A; Gurevich T; Mirelman A; Giladi N; Alcalay RN; Goldstein O; Orr-Urtreger A
Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38254936
[No Abstract] [Full Text] [Related]
3. Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue.
Tauber CV; Schwarz SC; Rösler TW; Arzberger T; Gentleman S; Windl O; Krumbiegel M; Reis A; Ruf VC; Herms J; Höglinger GU
Acta Neuropathol Commun; 2023 Mar; 11(1):40. PubMed ID: 36906636
[TBL] [Abstract][Full Text] [Related]
4. Tau haplotypes regulate transcription and are associated with Parkinson's disease.
Kwok JB; Teber ET; Loy C; Hallupp M; Nicholson G; Mellick GD; Buchanan DD; Silburn PA; Schofield PR
Ann Neurol; 2004 Mar; 55(3):329-34. PubMed ID: 14991810
[TBL] [Abstract][Full Text] [Related]
5. MAPT allele and haplotype frequencies in Nigerian Africans: Population distribution and association with Parkinson's disease risk and age at onset.
Okunoye O; Ojo OO; Abiodun O; Abubakar S; Achoru C; Adeniji O; Agabi O; Agulanna U; Akinyemi R; Ali M; Ani-Osheku I; Arigbodi O; Bello A; Erameh C; Farombi T; Fawale M; Imarhiagbe F; Iwuozo E; Komolafe M; Nwani P; Nwazor E; Nyandaiti Y; Obiabo Y; Odeniyi O; Odiase F; Ojini F; Onwuegbuzie G; Osaigbovo G; Osemwegie N; Oshinaike O; Otubogun F; Oyakhire S; Ozomma S; Samuel S; Taiwo F; Wahab K; Zubair Y; Hernandez D; Bandres-Ciga S; Blauwendraat C; Singleton A; Houlden H; Hardy J; Rizig M; Okubadejo N
Parkinsonism Relat Disord; 2023 Aug; 113():105517. PubMed ID: 37467655
[TBL] [Abstract][Full Text] [Related]
6. Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease.
Zabetian CP; Hutter CM; Factor SA; Nutt JG; Higgins DS; Griffith A; Roberts JW; Leis BC; Kay DM; Yearout D; Montimurro JS; Edwards KL; Samii A; Payami H
Ann Neurol; 2007 Aug; 62(2):137-44. PubMed ID: 17514749
[TBL] [Abstract][Full Text] [Related]
7. Common inversion polymorphism at 17q21.31 affects expression of multiple genes in tissue-specific manner.
de Jong S; Chepelev I; Janson E; Strengman E; van den Berg LH; Veldink JH; Ophoff RA
BMC Genomics; 2012 Sep; 13():458. PubMed ID: 22950410
[TBL] [Abstract][Full Text] [Related]
8. Different MAPT haplotypes are associated with Parkinson's disease and progressive supranuclear palsy.
Ezquerra M; Pastor P; Gaig C; Vidal-Taboada JM; Cruchaga C; Muñoz E; Martí MJ; Valldeoriola F; Aguilar M; Calopa M; Hernandez-Vara J; Tolosa E
Neurobiol Aging; 2011 Mar; 32(3):547.e11-6. PubMed ID: 19879020
[TBL] [Abstract][Full Text] [Related]
9. H1/H2 MAPT haplotype and Parkinson's disease in Mexican mestizo population.
Miranda-Morales EG; Sandoval-Carrillo A; Castellanos-Juárez FX; Méndez-Hernández EM; La Llave-León O; Quiñones-Canales G; Ruano-Calderón LA; Arias-Carrión O; Salas-Pacheco JM
Neurosci Lett; 2019 Jan; 690():210-213. PubMed ID: 30339920
[TBL] [Abstract][Full Text] [Related]
10. Haplotype-specific MAPT exon 3 expression regulated by common intronic polymorphisms associated with Parkinsonian disorders.
Lai MC; Bechy AL; Denk F; Collins E; Gavriliouk M; Zaugg JB; Ryan BJ; Wade-Martins R; Caffrey TM
Mol Neurodegener; 2017 Oct; 12(1):79. PubMed ID: 29084565
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide association study stratified by
Senkevich K; Bandres-Ciga S; Cisterna-García A; Yu E; Bustos BI; Krohn L; Lubbe SJ; Botía JA; ; Gan-Or Z
medRxiv; 2023 Apr; ():. PubMed ID: 37292720
[TBL] [Abstract][Full Text] [Related]
12. Association of MAPT subhaplotypes with clinical and demographic features in Parkinson's disease.
Deutschlander AB; Konno T; Soto-Beasley AI; Walton RL; van Gerpen JA; Uitti RJ; Heckman MG; Wszolek ZK; Ross OA
Ann Clin Transl Neurol; 2020 Sep; 7(9):1557-1563. PubMed ID: 32767721
[TBL] [Abstract][Full Text] [Related]
13. Brain hypometabolism in non-demented microtubule-associated protein tau H1 carriers with Parkinson's disease.
Gasca-Salas C; Trompeta C; López-Aguirre M; Rodríguez Rojas R; Clarimon J; Dols-Icardo O; El Bounasri S; Guida P; Mata-Marín D; Hernández-Fernández F; Marras C; García-Cañamaque L; Plaza de Las Heras I; Obeso I; Vela L; Fernández-Rodríguez B
J Neuroimaging; 2023; 33(6):953-959. PubMed ID: 37726927
[TBL] [Abstract][Full Text] [Related]
14. 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson's disease are associated with LRRC37A/2 expression in astrocytes.
Bowles KR; Pugh DA; Liu Y; Patel T; Renton AE; Bandres-Ciga S; Gan-Or Z; Heutink P; Siitonen A; Bertelsen S; Cherry JD; Karch CM; Frucht SJ; Kopell BH; Peter I; Park YJ; ; Charney A; Raj T; Crary JF; Goate AM
Mol Neurodegener; 2022 Jul; 17(1):48. PubMed ID: 35841044
[TBL] [Abstract][Full Text] [Related]
15. Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study.
Tobin JE; Latourelle JC; Lew MF; Klein C; Suchowersky O; Shill HA; Golbe LI; Mark MH; Growdon JH; Wooten GF; Racette BA; Perlmutter JS; Watts R; Guttman M; Baker KB; Goldwurm S; Pezzoli G; Singer C; Saint-Hilaire MH; Hendricks AE; Williamson S; Nagle MW; Wilk JB; Massood T; Laramie JM; DeStefano AL; Litvan I; Nicholson G; Corbett A; Isaacson S; Burn DJ; Chinnery PF; Pramstaller PP; Sherman S; Al-hinti J; Drasby E; Nance M; Moller AT; Ostergaard K; Roxburgh R; Snow B; Slevin JT; Cambi F; Gusella JF; Myers RH
Neurology; 2008 Jul; 71(1):28-34. PubMed ID: 18509094
[TBL] [Abstract][Full Text] [Related]
16.
Okunoye O; Ojo O; Abiodun O; Abubakar S; Achoru C; Adeniji O; Agabi O; Agulanna U; Akinyemi R; Ali M; Ani-Osheku I; Arigbodi O; Bello A; Erameh C; Farombi T; Fawale M; Imarhiagbe F; Iwuozo E; Komolafe M; Nwani P; Nwazor E; Nyandaiti Y; Obiabo Y; Odeniyi O; Odiase F; Ojini F; Onwuegbuzie G; Osaigbovo G; Osemwegie N; Oshinaike O; Otubogun F; Oyakhire S; Ozomma S; Samuel S; Taiwo F; Wahab K; Zubair Y; Hernandez D; Bandres-Ciga S; Blauwendraat C; Singleton A; Houlden H; Hardy J; Rizig M; Okubadejo N
medRxiv; 2023 Mar; ():. PubMed ID: 36993627
[TBL] [Abstract][Full Text] [Related]
17. The cerebral blood flow deficits in Parkinson's disease with mild cognitive impairment using arterial spin labeling MRI.
Arslan DB; Gurvit H; Genc O; Kicik A; Eryurek K; Cengiz S; Erdogdu E; Yildirim Z; Tufekcioglu Z; Uluğ AM; Bilgic B; Hanagasi H; Tuzun E; Demiralp T; Ozturk-Isik E
J Neural Transm (Vienna); 2020 Sep; 127(9):1285-1294. PubMed ID: 32632889
[TBL] [Abstract][Full Text] [Related]
18. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration.
Pittman AM; Myers AJ; Abou-Sleiman P; Fung HC; Kaleem M; Marlowe L; Duckworth J; Leung D; Williams D; Kilford L; Thomas N; Morris CM; Dickson D; Wood NW; Hardy J; Lees AJ; de Silva R
J Med Genet; 2005 Nov; 42(11):837-46. PubMed ID: 15792962
[TBL] [Abstract][Full Text] [Related]
19. Role of ethnicity on the association of MAPT H1 haplotypes and subhaplotypes in Parkinson's disease.
Winkler S; König IR; Lohmann-Hedrich K; Vieregge P; Kostic V; Klein C
Eur J Hum Genet; 2007 Nov; 15(11):1163-8. PubMed ID: 17637803
[TBL] [Abstract][Full Text] [Related]
20. Linkage disequilibrium and association of MAPT H1 in Parkinson disease.
Skipper L; Wilkes K; Toft M; Baker M; Lincoln S; Hulihan M; Ross OA; Hutton M; Aasly J; Farrer M
Am J Hum Genet; 2004 Oct; 75(4):669-77. PubMed ID: 15297935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
